Skip to main content

What the FDA labels say about taking them together

Ritonavir and zolpidem

Ritonavir's FDA label of July 23, 2026 names zolpidem in its drug interactions section; the zolpidem labels PlainMeds reads (4) do not name ritonavir. The ritonavir label: “A dose decrease may be needed for these drugs when co-administered with ritonavir.”

Check it at the source: the ritonavir FDA label on DailyMed (effective July 23, 2026, AbbVie Inc.); the zolpidem FDA label on DailyMed (effective August 15, 2022, Viatris Specialty LLC).

What does the ritonavir label say about zolpidem?

Ritonavir label, drug interactions

Concomitant Drug Class/Drug Name: Sedative/hypnotics: buspirone, clorazepate, diazepam, estazolam, flurazepam, zolpidem; Effect on Concentration of Ritonavir or Concomitant Drug: ↑ sedative/hypnotics; Clinical Comment: A dose decrease may be needed for these drugs when co-administered with ritonavir.

Source: FDA drug label (Norvir), AbbVie Inc., effective July 23, 2026 (SPL set 2849298e-de6e-47bb-8194-56e075b33fc3), via openFDA; the full label on DailyMed

What does the zolpidem label say about ritonavir?

Zolpidem's label (effective August 15, 2022) and its 3 other brand-application labels do not name ritonavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Edluar), Viatris Specialty LLC, effective August 15, 2022 (SPL set a32884d0-85b5-11de-8a39-0800200c9a66), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Ritonavir generic labelers
39Zolpidem generic labelers
RitonavirZolpidem
Labeled forHIVInsomnia
Boxed warningYesYes
Pharmacy cost (NADAC)$0.607 per tablet 100 mg tablet$0.0344 per tablet 5 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?